TeleTrader 2/22/2016 European markets jump-start trading week
TeleTrader 1/25/2016 European markets close lower, pressured by oil
GlobeNewswire 9/29/2015 Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
GlobeNewswire 9/14/2015 Sanofi Reports Positive Top-Line Results in Second Pivotal LixiLan Phase III Study
GlobeNewswire 8/14/2015 Ossur Hf : Share Options Granted
GlobeNewswire 3/27/2015 Bavarian Nordic A/S - Notice Convening Ordinary General Meeting
GlobeNewswire 3/26/2015 NNIT A/S: 13/2015 Stabilisation period ends
GlobeNewswire 3/19/2015 Sanofi Announces Top-Line Results for Cardiovascular Outcomes Study of Lyxumia® (lixisenatide)
GlobeNewswire 3/13/2015 Bavarian Nordic A/S - Major Shareholder Announcement
GlobeNewswire 3/11/2015 Bavarian Nordic Announces 2014 Full Year Results
GlobeNewswire 2/24/2015 Bavarian Nordic Announces Updated Overall Survival Data from Combination Immunotherapy Data of PROST...
GlobeNewswire 1/27/2015 Bavarian Nordic A/S - Major Shareholder Announcement
GlobeNewswire 1/6/2015 Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial for the Ebola Vaccine Regimen of MVA-...
GlobeNewswire 12/10/2014 Bavarian Nordic Reaches Enrollment Target in the Pivotal Phase 3 Study of PROSTVAC® in Prostate Canc...
GlobeNewswire 12/4/2014 Bavarian Nordic Announces First Subject Dosed with MVA-BN® Filo in a Phase 1 Study Investigating a N...
GlobeNewswire 11/18/2014 Bavarian Nordic A/S Issues New Shares in Connection with Exercise of Warrants
GlobeNewswire 11/13/2014 Bavarian Nordic Announces Interim Results for the First Nine Months of 2014
GlobeNewswire 11/6/2014 Bavarian Nordic to Host Third Quarter 2014 Results Conference Call
GlobeNewswire 10/29/2014 Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson &...
GlobeNewswire 10/22/2014 Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN® for Additional Infectious D...
GlobeNewswire 10/22/2014 Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Dev...
GlobeNewswire 10/22/2014 Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN® Ebola Vaccine
GlobeNewswire 9/24/2014 Onxeo announces participation in the Midcap Event On October 2nd and 3rd, 2014 in Paris
GlobeNewswire 9/4/2014 Bavarian Nordic Announces Exercise of Contract Option by the U.S. Government for Continued Supply of...
GlobeNewswire 9/4/2014 Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. Nation...